EI
DSCI

EAM Investors’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

EAM Investors’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-100,658
Closed -$1.25M – 428
2013
Q3 		$1.25M Sell
100,658
-7,676
-7% -$106K 0.25% 161
2013
Q2 		$1.45M Buy
+108,334
New +$1.39M 0.31% 106

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors's DSCI Position: Q4 2013 in Review

EAM Investors sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2013, closing a stake of 100,658 shares — an estimated $1.25M sold.

EAM Investors first reported a position in DSCI in Q2 2013 and held it in 2 quarters. The position peaked at $1.45M in Q2 2013. 55 funds tracked by Wall St. Rank hold DSCI as of Q4 2013.

  • EAM Investors reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2013 after selling out during the quarter.
  • EAM Investors sold 100,658 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2013, an estimated $1.25M.
  • EAM Investors first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 2 quarters.
  • EAM Investors's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.45M in Q2 2013.
  • 55 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2013.

Based on EAM Investors's 13F filing for Q4 2013, filed 14 Feb 2014.